Clinical Trial Update: Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression [NA]

View source ↗

Summary

A clinical trial evaluating single-fraction versus multi-fraction stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic disease and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastatic Disease
• Oligoprogression

Snippet

Sponsor: Robert Olson | Conditions: Oligometastatic Disease, Oligoprogression | NA | Status: RECRUITING